Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Z Gastroenterol ; 52(12): 1413-22, 2014 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-25474281

RESUMO

Endoscopic-retrograde cholangiopancreaticography (ERCP) is the method of choice for the treatment of surgical complications of the biliary system. Biliary leaks most frequently occur after cholecystectomy and partial liver resection. The most frequent complications after liver transplantation include biliary leaks, strictures and obstructive cholestasis. They are associated with significant morbidity and mortality as well as the risk of failure of the transplanted organ. The chance for a long-term successful therapy via ERCP is dependent on three main factors: (i) type, localisation and extent of the biliary damage, (ii) the time-point of appearance after surgery and (iii) the consequent accomplishment of the endoscopic therapy. In case of altered anatomy, e. g., hepatico- or choledocho-jejunostomy, endoscopic therapy can often be accomplished via an enteroscopic approach.


Assuntos
Doenças Biliares/patologia , Doenças Biliares/cirurgia , Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Endoscopia Gastrointestinal/métodos , Humanos
3.
Z Gastroenterol ; 50(12): 1310-32, 2012 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-23225560

RESUMO

The current recommendations on indications, technical performance, and interpretation of diagnostic techniques for oesophageal reflux update the German recommandations about 24 hour pH measurement of 2003. The recommendations encompass conventional pH measurement, wireless pH measurement, pH and impedance measurements, and bilirubin measurement (duodenogastro-oesophageal reflux).


Assuntos
Bilirrubina/sangue , Determinação da Acidez Gástrica , Gastroenterologia/normas , Refluxo Gastroesofágico/diagnóstico , Concentração de Íons de Hidrogênio , Pletismografia de Impedância/normas , Guias de Prática Clínica como Assunto , Alemanha , Humanos
4.
Internist (Berl) ; 51(11): 1439-45, 2010 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-20628718

RESUMO

In patients with carcinoid syndrome, there has always to be considered cardiac impairment. We report about two patients with hepatic and bone metastases of a neuroendocrine tumor of the midgut, who suffered from progressive dyspnea. This was caused in both cases by a right-to-left atrial shunt, in case 1 based on a patent foramen ovale (PFO), in case 2 based on a secundum atrial septal defect. Symptoms were significantly reduced by percutaneous closure of PFO and ASD, respectively. Right-to-left atrial shunt was facilitated by right-sided carcinoid induced endocardial fibrosis with the consequence of severe tricuspid regurgitation, leading to an increase of right atrial pressure.


Assuntos
Doença Cardíaca Carcinoide/diagnóstico , Dispneia/etiologia , Forame Oval Patente/diagnóstico , Síndrome do Carcinoide Maligno/diagnóstico , Idoso , Doença Cardíaca Carcinoide/terapia , Tumor Carcinoide/diagnóstico , Tumor Carcinoide/terapia , Terapia Combinada , Ecocardiografia Transesofagiana , Feminino , Forame Oval Patente/terapia , Humanos , Neoplasias do Íleo/diagnóstico , Neoplasias do Íleo/terapia , Imageamento por Ressonância Magnética , Síndrome do Carcinoide Maligno/terapia , Pessoa de Meia-Idade , Dispositivo para Oclusão Septal , Insuficiência da Valva Tricúspide/diagnóstico , Insuficiência da Valva Tricúspide/terapia
5.
Z Gastroenterol ; 47(9): 830-45, 2009 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-19750432

RESUMO

Esophageal manometry examines the pressure profiles of the tubular esophagus and of the esophageal sphincters during resting conditions and in response to swallowing. It is regarded as the reference method for detection of esophageal motility disturbances but, up to date, performance of the procedure is not standardized among centers. This review depicts the recommendations of the German Societies for Neurogastroenterology and Motility, for Digestive and Metabolic Disturbances and for General and Visceral Surgery on indications, performance and analysis of conventional esophageal manometry. In addition to concise recommendations we give detailed background information so that the article can serve as a practical guideline for inexperienced investigators as well as an exensive review for the experienced one. Moreover, recommendations on the use of newer and/or supplementary diagnostic techniques, that is long-term and high resolution manometry as well as esophageal impedance measurements are also given.


Assuntos
Transtornos da Motilidade Esofágica/diagnóstico , Gastroenterologia/normas , Manometria/normas , Alemanha , Humanos , Guias de Prática Clínica como Assunto
6.
Neurogastroenterol Motil ; 21(6): 609-18, e21-2, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19220754

RESUMO

The gut-born incretin hormone glucagon-like peptide-1 (GLP-1) delays gastric emptying. To elucidate the mechanisms by which GLP-1 affects gastroduodenal motility and glycaemia, we studied the effects of exendin(9-39), a potent GLP-1 receptor antagonist, on gastroduodenal motility and pancreatic hormones. In this randomized, double-blind, placebo-controlled, four-arm, cross-over trial, 10 healthy volunteers were studied during the interdigestive period followed by duodenal perfusion of a mixed liquid meal (250 kcal). On four separate days, exendin(9-39), atropine, exendin(9-39) + atropine or saline were infused intravenously. Antro-pyloro-duodenal and fundic motility were assessed. The compliance of the proximal stomach was determined by isobaric distensions. During fasting, exendin(9-39) did not influence proximal gastric volume, pyloric tone, and duodenal contractility. Exendin(9-39) significantly increased antral waves only in the absence of atropine. During duodenal meal perfusion, exendin(9-39) significantly reduced proximal gastric volume accommodation, abbreviated postprandial antral inhibition, reduced the postprandial increase in pyloric tone, and reduced gastric compliance. Atropine abolished the effects of exendin(9-39) on gastric volume accommodation but did not affect its effects on postprandial antroduodenal motility and on gastric compliance. Exendin(9-39) increased fasting and postprandial glycaemia and plasma glucagon but not insulin concentrations. Atropine did not affect GLP-1 secretion. Cholinergic mechanisms mediate the effects of GLP-1 on postprandial gastric accommodation but not on antro-pyloro-duodenal motility. GLP-1 reduces fasting and postprandial glycaemia, in part by reducing glucagon secretion.


Assuntos
Vias Autônomas/fisiologia , Duodeno/inervação , Duodeno/fisiologia , Motilidade Gastrointestinal/fisiologia , Peptídeo 1 Semelhante ao Glucagon/fisiologia , Sistema Nervoso Parassimpático/fisiologia , Estômago/inervação , Estômago/fisiologia , Adulto , Atropina/farmacologia , Vias Autônomas/efeitos dos fármacos , Glicemia/metabolismo , Método Duplo-Cego , Duodeno/efeitos dos fármacos , Ingestão de Alimentos/fisiologia , Motilidade Gastrointestinal/efeitos dos fármacos , Peptídeo 1 Semelhante ao Glucagon/agonistas , Receptor do Peptídeo Semelhante ao Glucagon 1 , Hormônios/sangue , Humanos , Masculino , Antagonistas Muscarínicos/farmacologia , Sistema Nervoso Parassimpático/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Receptores de Glucagon/antagonistas & inibidores , Estômago/efeitos dos fármacos
7.
Gut ; 58(2): 241-8, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18852257

RESUMO

BACKGROUND AND AIMS: This prospective trial was designed to compare the performance characteristics of five different screening tests in parallel for the detection of advanced colonic neoplasia: CT colonography (CTC), colonoscopy (OC), flexible sigmoidoscopy (FS), faecal immunochemical stool testing (FIT) and faecal occult blood testing (FOBT). METHODS: Average risk adults provided stool specimens for FOBT and FIT, and underwent same-day low-dose 64-multidetector row CTC and OC using segmentally unblinded OC as the standard of reference. Sensitivities and specificities were calculated for each single test, and for combinations of FS and stool tests. CTC radiation exposure was measured, and patient comfort levels and preferences were assessed by questionnaire. RESULTS: 221 adenomas were detected in 307 subjects who completed CTC (mean radiation dose, 4.5 mSv) and OC; 269 patients provided stool samples for both FOBT and FIT. Sensitivities of OC, CTC, FS, FIT and FOBT for advanced colonic neoplasia were 100% (95% CI 88.4% to 100%), 96.7% (82.8% to 99.9%), 83.3% (95% CI 65.3% to 94.4%), 32% (95% CI 14.9% to 53.5) and 20% (95% CI 6.8% to 40.7%), respectively. Combination of FS with FOBT or FIT led to no relevant increase in sensitivity. 12 of 45 advanced adenomas were smaller than 10 mm. 46% of patients preferred CTC and 37% preferred OC (p<0.001). CONCLUSIONS: High-resolution and low-dose CTC is feasible for colorectal cancer screening and reaches sensitivities comparable with OC for polyps >5 mm. For patients who refuse full bowel preparation and OC or CTC, FS should be preferred over stool tests. However, in cases where stool tests are performed, FIT should be recommended rather than FOBT.


Assuntos
Adenoma/diagnóstico , Neoplasias Colorretais/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Colo/patologia , Pólipos do Colo/diagnóstico , Colonografia Tomográfica Computadorizada/métodos , Colonoscopia/métodos , Fezes/química , Feminino , Hemoglobinas/análise , Humanos , Imageamento Tridimensional , Masculino , Pessoa de Meia-Idade , Sangue Oculto , Estudos Prospectivos , Reto/patologia , Tamanho da Amostra , Sensibilidade e Especificidade , Sigmoidoscopia/métodos , Gravação em Vídeo
8.
Z Gastroenterol ; 46(1): 58-68, 2008 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-18188818

RESUMO

The diagnosis of and therapy for cholangiocarcinomas still remains an interdisciplinary challenge. For diagnostic and therapeutic purposes intra- and extrahepatic cholangiocarcinomas need to be distinguished. Multiple imaging tools such as sonography, multidetector computer tomography, magnetic resonance tomography as well as endoscopic ultrasound and endoscopic retrograde cholangiography for the diagnosis and localisation of these tumours are available. To date, surgical resection is the only curative treatment. At the time of diagnosis, most of the tumours are advanced. Therefore, only a small percentage of patients are suitable for curative surgery. Infiltration of the portal vein no longer constitutes a contraindication for surgery. Liver transplantation is not a reasonable option for intrahepatic cholangiocarcinomas but may be of advantage for perihilar Klatskin tumours. Severe cholangitis is the main cause of death of patients with obstructive cholangiocarcinomas. Drainage of the biliary tree system or surgery with construction of a biliary-digestive anastomosis is often necessary. If possible, a photodynamic therapy (PDT) should be performed in addition to biliary drainage. PDT has been shown to facilitate biliary drainage and to improve survival. The value of radiologist-assisted interventional procedures as well as percutaneous ablation and radiochemotherapy is not well established. In addition, so far, there is no standardised chemotherapy in a palliative situation established but there is some evidence for a benefit of gemcitabine-based chemotherapy. For the best care and treatment of patients with cholangiocarcinomas an interdisciplinary approach is required and to achieve progress in the therapy patients should be included in prospective clinical trials to test new approaches.


Assuntos
Neoplasias dos Ductos Biliares , Ductos Biliares Intra-Hepáticos , Colangiocarcinoma , Ducto Hepático Comum , Tumor de Klatskin , Algoritmos , Antimetabólitos Antineoplásicos/uso terapêutico , Neoplasias dos Ductos Biliares/diagnóstico , Neoplasias dos Ductos Biliares/diagnóstico por imagem , Neoplasias dos Ductos Biliares/tratamento farmacológico , Neoplasias dos Ductos Biliares/mortalidade , Neoplasias dos Ductos Biliares/cirurgia , Ductos Biliares Intra-Hepáticos/diagnóstico por imagem , Ductos Biliares Intra-Hepáticos/cirurgia , Colangiocarcinoma/diagnóstico , Colangiocarcinoma/diagnóstico por imagem , Colangiocarcinoma/tratamento farmacológico , Colangiocarcinoma/mortalidade , Colangiocarcinoma/cirurgia , Colangiopancreatografia Retrógrada Endoscópica , Desoxicitidina/análogos & derivados , Desoxicitidina/uso terapêutico , Drenagem , Endossonografia , Humanos , Tumor de Klatskin/diagnóstico , Tumor de Klatskin/cirurgia , Transplante de Fígado , Imageamento por Ressonância Magnética , Tomografia Computadorizada por Raios X , Gencitabina
9.
Am J Physiol Endocrinol Metab ; 294(1): E103-9, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17971511

RESUMO

OBJECTIVE: Regulation of postprandial (pp) plasma glucose excursions is complex. Insulin and glucagon are thought to play the predominant role. Nevertheless, only 50% of the variation in pp plasma glucose excursions is explained by variations by the latter. Theoretically, gastric emptying (GE) should be another important factor. However, its impact on pp glucose homeostasis is unknown. RESEARCH DESIGN AND METHODS: We examined the consequences of pramlintide-induced delay in GE on pp glycemia and glucose fluxes, determined isotopically. GE was recorded by scintigraphy. Fourteen healthy subjects (8 men, 6 women; age 40 +/- 3 yr, body mass index 27.8 +/- 1.1 kg/m2) ate a mixed meal, and 30 microg of pramlintide (PRAM) or placebo (PBO) were injected subcutaneously. RESULTS: At 60 min, greater proportions of the initial gastric contents remained in the stomach (PBO vs. PRAM). Thereafter, GE slopes paralleled until 240 min. Fifty percent retention times were lower when PBO was given (P < 0.001). GE was greater from 240 min to the end of the PRAM experiments, so that only slightly greater proportions of the meal remained in the stomach at 330 min. Reductions of GE lowered pp glucose (7.5 +/- 0.3 vs. 6.0 +/- 0.2 mmol/l, P < 0.001), even though plasma insulin was lower with PRAM (164 +/- 13 vs. 138 +/- 13 pmol/ml, both P < 0.01). Reduction in total glucose appearance (P < 0.001) was due to reduced meal-derived glucose appearance (10.2 +/- 0.5 vs. 7.0 +/- 0.4 micromol.kg(-1).min(-1), P < 0.001). Endogenous glucose appearance was greater with PRAM (P < 0.001). Splanchnic glucose uptake was greater with PRAM (26.5 +/- 1.6 vs. 32.5 +/- 2.1%, P = 0.014). CONCLUSIONS: These data support the concept that GE is an important physiological regulator of pp glucose homeostasis in humans.


Assuntos
Glicemia/metabolismo , Esvaziamento Gástrico/fisiologia , Homeostase/fisiologia , Período Pós-Prandial/fisiologia , Adulto , Amiloide/administração & dosagem , Feminino , Esvaziamento Gástrico/efeitos dos fármacos , Glucagon/sangue , Homeostase/efeitos dos fármacos , Humanos , Hipoglicemiantes/administração & dosagem , Insulina/sangue , Polipeptídeo Amiloide das Ilhotas Pancreáticas , Masculino , Placebos , Período Pós-Prandial/efeitos dos fármacos , Análise de Regressão , Circulação Esplâncnica/fisiologia , Fatores de Tempo
10.
MMW Fortschr Med ; 149(29-30): 51-4, 2007 Jul 19.
Artigo em Alemão | MEDLINE | ID: mdl-17703693

RESUMO

Proton pump inhibitors (PPI) are currently the standard treatment for reflux disease. A symptom correlated diagnosis with the help of 24-h-pH-metry and/or multiple intraluminal impedance (MII) allows the objective and differentiated classification of endoscopy-negative patients despite PPI symptoms.


Assuntos
Antiulcerosos/uso terapêutico , Esofagite Péptica/tratamento farmacológico , Esofagoscopia , Algoritmos , Antiácidos/uso terapêutico , Terapia Combinada , Impedância Elétrica , Monitoramento do pH Esofágico , Esofagite Péptica/diagnóstico , Esofagite Péptica/etiologia , Fundoplicatura , Humanos , Inibidores da Bomba de Prótons , Recidiva
11.
Phytomedicine ; 13 Suppl 5: 80-9, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16713219

RESUMO

STW 5 (Iberogast), a phytomedicine agent consisting of a fixed combination of nine individual plant extracts, is widely used in the treatment of dyspepsia and motility related disorders. Little if anything is known on the possible influence on electrophysiological properties of intestinal smooth muscle by which STW 5 causes its beneficial effects. The aim of the present study was to investigate whether herbal extracts influence electrophysiological parameters of large and small intestine. For this purpose intracellular recordings of smooth muscle cell (SMC) of the circular muscle layer of different parts of mouse intestine were performed using standard microelectrode techniques. The resting membrane potential (RMP), excitatory and inhibitory neurotransmission in proximal colon, the frequency and the amplitude of slow waves in small intestine were investigated. The RMP of SMC was -46.4+/-3.8 mV, n=11 in the colon and -59+/-1.3 mV, n=15 in small intestine. STW 5 significantly depolarized the RMP of colonic (16.6+/-2.2 mV, n=6, p<0.05) and jejunal (9.6+/-1.6 mV, n=7, p<0.05) SMC. This depolarizing effect can be mainly attributed to the constituents of chamomile flower, Angelica root and greater celandine herb. Following the electrical field stimulations (EFSs), junction potentials are influenced in a distinct manner. Excitatory junctions potentials (EJPs) of the colon were not significantly reduced (13.1+/-4.8 vs. 10.1+/-2.8 n.s., n=6) but fast (fIJP) and slow (sIJP) inhibitory junction potentials of the murine colon are reduced significantly by STW 5 (fIJP: 21.6+/-8.1 vs. 11.6+/-2.1 and sIJP: 12.1+/-3.3 vs. 6.1+/-1.3 n=6, p<0.05). The basal frequency of small intestinal slow waves was 39.5+/-1.4 min(-1) and the amplitude was 23.1+/-0.9 mV, n=15. STW 5 significantly reduced amplitude and frequency of the slow waves (11.7+/-0.8 mV; 33.5+/-3.4 min(-1), n=6, p<0.05). This effect on slow waves represents the summation of effects of the nine individual phytoextracts. Whereas Angelica root and chamomile flower completely blocked the slow wave activity, bitter candy tuft increased the frequency and amplitude, greater celandine herb reduced frequency and amplitude of the slow wave, peppermint leaf reduced frequency and left amplitude unchanged and liquorice root, caraway fruit and lemon balm leaf had no effects in basic electrophysiological properties of SMC. This study demonstrates that STW 5 causes changes in SMC RMP, excitatory and inhibitory neurotransmission and slow wave rhythmicity. These effects represent a summation effect of different constituents of this phytotherapeuticum and prove that STW 5 has characteristic effects on intestinal electrophysiology.


Assuntos
Intestinos/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , Miócitos de Músculo Liso/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Eletrofisiologia , Etanol , Técnicas In Vitro , Camundongos , Camundongos Endogâmicos BALB C
12.
Gut ; 55(2): 243-51, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15985560

RESUMO

BACKGROUND: Exogenous use of the intestinal hormone glucagon-like peptide 1 (GLP-1) lowers glycaemia by stimulation of insulin, inhibition of glucagon, and delay of gastric emptying. AIMS: To assess the effects of endogenous GLP-1 on endocrine pancreatic secretion and antro-pyloro-duodenal motility by utilising the GLP-1 receptor antagonist exendin(9-39)amide (ex(9-39)NH2). METHODS: Nine healthy volunteers underwent four experiments each. In two experiments with and without intravenous infusion of ex(9-39)NH2 300 pmol/kg/min, a fasting period was followed by intraduodenal glucose perfusion at 1 and 2.5 kcal/min, with the higher dose stimulating GLP-1 release. Antro-pyloro-duodenal motility was measured by perfusion manometry. To calculate the incretin effect (that is, the proportion of plasma insulin stimulated by intestinal hormones) the glycaemia observed during the luminal glucose experiments was mimicked using intravenous glucose in two further experiments. RESULTS: Ex(9-39)NH2 significantly increased glycaemia during fasting and duodenal glucose. It diminished plasma insulin during duodenal glucose and significantly reduced the incretin effect by approximately 50%. Ex(9-39)NH2 raised plasma glucagon during fasting and abolished the decrease in glucagon at the high duodenal glucose load. Ex(9-39)NH2 markedly stimulated antroduodenal contractility. At low duodenal glucose it reduced the stimulation of tonic and phasic pyloric motility. At the high duodenal glucose load it abolished pyloric stimulation. CONCLUSIONS: Endogenous GLP-1 stimulates postprandial insulin release. The pancreatic alpha cell is under the tonic inhibitory control of GLP-1 thereby suppressing postprandial glucagon. GLP-1 tonically inhibits antroduodenal motility and mediates the postprandial inhibition of antral and stimulation of pyloric motility. We therefore suggest GLP-1 as a true incretin hormone and enterogastrone in humans.


Assuntos
Motilidade Gastrointestinal/fisiologia , Peptídeo 1 Semelhante ao Glucagon/fisiologia , Ilhotas Pancreáticas/metabolismo , Adulto , Glicemia/metabolismo , Duodeno/fisiologia , Jejum/fisiologia , Esvaziamento Gástrico/efeitos dos fármacos , Esvaziamento Gástrico/fisiologia , Receptor do Peptídeo Semelhante ao Glucagon 1 , Técnica Clamp de Glucose/métodos , Humanos , Insulina/sangue , Insulina/metabolismo , Secreção de Insulina , Masculino , Manometria/métodos , Fragmentos de Peptídeos/farmacologia , Período Pós-Prandial/fisiologia , Antro Pilórico/fisiologia , Receptores de Glucagon/antagonistas & inibidores
13.
Z Gastroenterol ; 43(9): 1071-90, 2005 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-16142616

RESUMO

H (2)- and (13)C-breath tests are valuable non-invasive diagnostic tools for gastroenterological diseases. H (2)-breath tests are clinically established for the diagnosis of carbohydrate intolerance resulting from malabsorption (H (2)-breath tests with lactose, fructose, saccharose, sorbitol), of bacterial overgrowth (glucose H (2)-breath test) and for measurement of orcoceal transit time (lactulose H (2)-breath test). The (13)C-urea breath test is regarded as the "gold standard" procedure for the diagnosis of Helicobacter pylori infection. Moreover, (13)C-breath tests for measurement of gastric emptying can be considered as clinically established, meanwhile. (13)C-breath tests for the evaluation of pancreatic exocrine function or liver function can also be used clinically; however, they currently offer no substantial advantage over other diagnostic procedures. A major disadvantage of all breath tests is that they lack standardization although modifications of the test meal or solution, of the test performance and of the evaluation of data may markedly influence the results. Thus, this article presents the recommendations of the German Society of Neurogastroenterology and Motility and of the German Society of Digestive and Metabolic Diseases for clinically relevant H (2)- and (13)C-breath tests. Indications for the examinations, the procedures to be followed, the analysis of the obtained data and the conclusions to be drawn are delineated. The literature on which the recommendations are based is reviewed. However, personal experience of the authors is also taken into account since numerous questions regarding optimal test performance are not clarified by adequate studies.


Assuntos
Testes Respiratórios/métodos , Gastroenterologia/métodos , Gastroenterologia/normas , Gastroenteropatias/diagnóstico , Guias de Prática Clínica como Assunto , Padrões de Prática Médica/normas , Sociedades Médicas , Alemanha , Humanos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
14.
Dtsch Med Wochenschr ; 130(6): 266-9, 2005 Feb 11.
Artigo em Alemão | MEDLINE | ID: mdl-15692899

RESUMO

HISTORY AND ADMISSION FINDINGS: A 67-year-old man complained of recurrent retrosternal pain for 3 - 5 minutes as the only symptom for 3 - 4 years. Only when dysphagia occurred in the course of the disease was a gastroenterologist consulted. INVESTIGATIONS: The diagnosis of diffuse esophageal spasm was confirmed by esophageal manometry and radiology. Upper gastrointestinal endoscopy revealed no further pathological findings. TREATMENT AND COURSE: 100 units of botulinum toxin were injected in 10 divided doses, into the tubular esophagus, 1 cm apart, beginning at the z-line of the gastroesophageal junction, deeply into the muscular coat of the posterior part of the esophageal wall. This achieved improvement of symptoms as well as esophageal transit time measured by scintigraphy. The symptomatic benefit has now lasted for several months. CONCLUSION: The treatment of patients with diffuse esophageal spasm with botulinum toxin is a promising therapeutic option, which can be safely performed in such patients. But this regime needs evaluation in controlled prospective clinical studies.


Assuntos
Toxinas Botulínicas/administração & dosagem , Espasmo Esofágico Difuso/tratamento farmacológico , Esofagoscopia , Idoso , Relação Dose-Resposta a Droga , Esquema de Medicação , Trânsito Gastrointestinal/efeitos dos fármacos , Humanos , Injeções Intramusculares , Masculino , Resultado do Tratamento
15.
Digestion ; 70(4): 257-64, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15687728

RESUMO

BACKGROUND: Herbal preparations like STW 5 (Iberogast) are widely used drugs in the treatment of dyspepsia and motility-related disorders of the gastrointestinal tract. STW 5 is a phytotherapeutic agent consisting of a fixed mixture of 9 individual plant extracts. The electrophysiological mechanisms of action of STW 5 remain obscure. AIM: The aim of the present study was to investigate whether herbal extracts influence electrophysiological parameters of the small intestine. For this purpose, the resting membrane potential (RMP) and the slow wave rhythmicity of smooth muscle cells of mouse small intestine were observed. METHODS: Intracellular recordings of smooth muscle cells of the circular muscle layer of mouse small intestine were performed using standard microelectrode techniques. After dissection of the mucosa, the small intestine was placed in an organ bath and a microelectrode was applied on a circular smooth muscle cell. The RMP and the amplitude of slow waves were measured in millivolts. RESULTS: The RMP of smooth muscle cells was -59 +/- 1.3 mV. This RMP was significantly depolarized by STW 5 (9.6 +/- 1.6 mV); the depolarizing effects can be mainly attributed to the constituents of matricariae flos, angelicae radix and chelidonii herba. The basal frequency of small intestinal slow waves was 39.5 +/- 1.4 min(-1) and the amplitude was 23.1 +/- 0.9 mV. STW 5 significantly reduced the amplitude and frequency of the slow waves (11.7 +/- 0.8 mV; 33.5 +/- 3.4 min(-1)). This effect on slow waves represents the sum of the effects of the 9 phytoextracts. Whereas angelicae radix and matricariae flos completely blocked slow wave activity, Iberis amara increased the frequency and amplitude, chelidonii herba reduced the frequency and amplitude of the slow waves, mentae piperitae folium reduced the frequency and left amplitude unchanged and liquiritae radix, carvi fructus and melissae folium had no effects. CONCLUSION: Herbal extracts cause changes in smooth muscle RMP and slow wave rhythmicity, up to reversible abolition, by blockade of large conductance Ca2+ channels and other not yet identified mechanisms. In herbal preparations like STW 5 these effects add up to a total effect and this study indicates that herbal preparations which are widely used in dyspepsia and motility-related disorders have characteristic, reproducible, reversible effects on small intestinal electrophysiology.


Assuntos
Motilidade Gastrointestinal/efeitos dos fármacos , Medicina Herbária , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/fisiologia , Músculo Liso/efeitos dos fármacos , Músculo Liso/fisiologia , Extratos Vegetais/farmacologia , Animais , Eletrofisiologia , Masculino , Potenciais da Membrana , Camundongos , Camundongos Endogâmicos BALB C , Técnicas de Cultura de Tecidos
16.
Gut ; 50(3): 341-8, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11839712

RESUMO

BACKGROUND: Glucagon-like peptide-1(7-36)amide (GLP-1) retards gastric emptying, reduces food intake, and inhibits antroduodenal and stimulates pyloric motility. AIMS: To assess the effects of synthetic GLP-1 on fundus tone and volume waves, gastric compliance, and perception of gastric distension. SUBJECTS: Eleven healthy male volunteers. METHODS: Background infusions were saline, or GLP-1 at 0.3 or 0.9 pmol/ kg/min on separate days in random order. Interdigestive fundus motility was recorded by barostat (maximum capacity of intragastric bag 1200 ml) during basal and peptide periods of 60 minutes each. Thereafter stepwise isobaric distensions were performed with ongoing peptide infusion, and gastric sensation was scored. RESULTS: Low and high loads of GLP-1 induced physiological and supraphysiological plasma immunoreactivities, respectively. GLP-1 dose dependently diminished fundus tone (162.9 (15.0) and 259.5 (17.2) v 121.1 (6.0) ml with saline; p<0.0001). It greatly reduced volume waves and total volume displaced by these events (p<0.0001). Gastric compliance derived from isobaric distension rose in a dose related manner (42.6 (5.5) and 63.6 (7.7) v 27.0 (3.5) ml/mm Hg; p=0.0004) with a concomitant reduction of the pressure at half maximum bag volume (6.4 (0.4) and 5.5 (0.4) v 7.2 (0.1) mm Hg; p<0.0001). GLP-1 did not change perception of isobaric distension but reduced the perception score related to corresponding bag volume (p<0.0001). CONCLUSIONS: GLP-1 is a candidate physiological inhibitory regulator of fundus motility. It allows the stomach to afford a larger volume without increase in sensation.


Assuntos
Esvaziamento Gástrico/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Resposta de Saciedade/efeitos dos fármacos , Adulto , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Fundo Gástrico/efeitos dos fármacos , Fundo Gástrico/fisiologia , Hormônios Gastrointestinais/sangue , Glucagon , Peptídeo 1 Semelhante ao Glucagon , Peptídeos Semelhantes ao Glucagon , Humanos , Masculino , Relaxamento Muscular/efeitos dos fármacos , Pressão
17.
Clin Endocrinol (Oxf) ; 52(5): 617-23, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10792342

RESUMO

OBJECTIVE: Modern imaging techniques are detecting adrenal incidentalomas with increasing frequency. Recent data suggests food-dependent hypercortisolism in a subgroup of patients with bilateral macronodular hyperplasia due to aberrant adrenal responsiveness to gastric inhibitory polypeptide (GIP). We studied the putative influence of food intake on the hypothalamo-pituitary-adrenal (HPA) axis in patients with adrenal incidentalomas and possible mediation by GIP. PATIENTS AND MEASUREMENTS: We examined 15 mildly obese patients with adrenal incidentalomas, eight healthy, lean subjects, and seven obese patients with the metabolic syndrome, who were matched for body weight and age. Each individual underwent oral glucose tolerance testing (OGTT, 75 g glucose), i.v. glucose administration (IVGTT, 30 g glucose over 1 h) and i.v. glucose plus GIP infusion (body weight adapted leading to physiological postprandial GIP serum levels) on three occasions. Plasma glucose, ACTH and cortisol were measured from blood samples taken every 15 minutes from time - 30 minutes to + 75 minutes. RESULTS: OGTT, i.v. glucose administration and GIP infusion led to comparable glucose values within the groups. In contrast to normal subjects and patients with the metabolic syndrome, patients with adrenal incidentalomas had significantly higher mean cortisol values after oral glucose intake as compared to i.v. glucose administration or GIP infusion. The increase in cortisol levels was preceded by a corresponding ACTH increase. No significant effect of GIP administration on cortisol or on ACTH secretion could be detected. CONCLUSIONS: Patients with adrenal incidentalomas showed an abnormal responsiveness of the pituitary-adrenal axis to oral glucose administration. The cortisol peaks in these patients seemed to be ACTH-mediated and were not induced by GIP.


Assuntos
Adenoma/fisiopatologia , Neoplasias do Córtex Suprarrenal/fisiopatologia , Glucose/administração & dosagem , Sistema Hipotálamo-Hipofisário/fisiopatologia , Sistema Hipófise-Suprarrenal/fisiopatologia , Adenoma/sangue , Administração Oral , Neoplasias do Córtex Suprarrenal/sangue , Hormônio Adrenocorticotrópico/sangue , Adulto , Área Sob a Curva , Glicemia/análise , Estudos de Casos e Controles , Feminino , Polipeptídeo Inibidor Gástrico/administração & dosagem , Teste de Tolerância a Glucose , Humanos , Hidrocortisona/sangue , Infusões Intravenosas , Injeções Intravenosas , Resistência à Insulina , Masculino
18.
Gut ; 46(5): 622-31, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10764704

RESUMO

BACKGROUND: Glucagon-like peptide-1(7-36)amide (GLP-1) is a gut hormone released postprandially. Synthetic GLP-1 strongly inhibits gastric emptying in healthy subjects and in patients with diabetes mellitus. AIMS: To investigate the effects of GLP-1 on antro-pyloro-duodenal motility in humans. METHODS: Eleven healthy male volunteers were studied on two separate days. On the interdigestive study day, a basal period was followed by a 60 minute period of saline infusion and two further 60 minute periods of intravenous infusion of GLP-1 0.4 and 1.2 pmol/kg/min to achieve postprandial and supraphysiological plasma levels, respectively. On the postprandial study day, the same infusions were coadministered with intraduodenal lipid perfusion at 2.5 ml/min (2.5 kcal/min) followed by another 60 minutes of recording after cessation of GLP-1. Antro-pyloro-duodenal motility was measured by perfusion manometry. RESULTS: GLP-1 significantly inhibited the number and amplitudes of antral and duodenal contractions in the interdigestive state and after administration of duodenal lipid. It abolished interdigestive antral wave propagation. In the interdigestive state, GLP-1 dose dependently increased pyloric tone and significantly stimulated isolated pyloric pressure waves (IPPW). Pyloric tone increased with duodenal lipid, and this was further enhanced by GLP-1. GLP-1 transiently restored the initial IPPW response to duodenal lipid which had declined with lipid perfusion. Plasma levels of pancreatic polypeptide were dose dependently diminished by GLP-1 with and without duodenal lipid. CONCLUSIONS: GLP-1 inhibited antro-duodenal contractility and stimulated the tonic and phasic motility of the pylorus. These effects probably mediate delayed gastric emptying. Inhibition of efferent vagal activity may be an important mechanism. As postprandial plasma levels of GLP-1 are sufficient to appreciably affect motility, we believe that endogenous GLP-1 is a physiological regulator of motor activity in the antro-pyloro-duodenal region.


Assuntos
Duodeno/efeitos dos fármacos , Motilidade Gastrointestinal/efeitos dos fármacos , Glucagon/farmacologia , Fragmentos de Peptídeos/farmacologia , Período Pós-Prandial/efeitos dos fármacos , Precursores de Proteínas/farmacologia , Adulto , Duodeno/fisiologia , Esvaziamento Gástrico/efeitos dos fármacos , Esvaziamento Gástrico/fisiologia , Motilidade Gastrointestinal/fisiologia , Peptídeo 1 Semelhante ao Glucagon , Humanos , Lipídeos/administração & dosagem , Masculino , Manometria , Período Pós-Prandial/fisiologia , Pressão , Antro Pilórico/efeitos dos fármacos , Antro Pilórico/fisiologia , Fatores de Tempo
19.
Aliment Pharmacol Ther ; 14(1): 113-22, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10632654

RESUMO

BACKGROUND: This study was conducted to assess the efficacy of a novel 40-mg extended-release formulation of cisapride in reducing gastro-oesophageal reflux. METHODS: According to a double-blind, randomized, placebo-controlled design, 19 patients with pathological gastro-oesophageal reflux were treated with extended (40 mg o.d.) or immediate (10 mg q.d.s.) release formulations for two periods of 4 days each (pH-monitoring on day four). Patients received identical treatments in both periods to allow limits of agreement defining equivalent potency of both formulations to be derived from intra-individual variability of treatment effects. RESULTS: The extended-release formulation decreased total and upright reflux times by 5.5 +/- 1.3% and 8.1 +/- 2.1% (P < 0.001), respectively. It did not change the percentage supine reflux time but diminished the mean duration of reflux episodes by 1.0 +/- 0.4 min (P=0.005). The total number of reflux episodes remained unaltered with both formulations. Immediately-released cisapride decreased total, upright, and supine acid exposures by 5.8 +/- 1.3%, 6.8 +/- 1.6% (P < 0.002) and 3.6 +/- 1.8%, respectively, and mean duration of episodes by 0.9 +/- 0.2 min (P

Assuntos
Cisaprida/uso terapêutico , Refluxo Gastroesofágico/tratamento farmacológico , Fármacos Gastrointestinais/uso terapêutico , Adolescente , Adulto , Idoso , Cisaprida/administração & dosagem , Cisaprida/efeitos adversos , Preparações de Ação Retardada , Método Duplo-Cego , Esôfago/química , Esôfago/metabolismo , Feminino , Fármacos Gastrointestinais/administração & dosagem , Fármacos Gastrointestinais/efeitos adversos , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade
20.
J Clin Invest ; 101(7): 1421-30, 1998 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9525985

RESUMO

The gastrointestinal hormone, glucagon-like peptide-1(7-36)amide (GLP-1) is released after a meal. The potency of synthetic GLP-1 in stimulating insulin secretion and in inhibiting glucagon secretion indicates the putative physiological function of GLP-1. In vitro, the nonmammalian peptide, exendin(9-39)amide [ex(9-39)NH2], is a specific and competitive antagonist of GLP-1. This in vivo study examined the efficacy of ex(9-39)NH2 as an antagonist of exogenous GLP-1 and the physiological role of endogenous GLP-1. Six healthy volunteers underwent 10 experiments in random order. In each experiment, a 30-min period of euglycemia was followed by an intravenous infusion of glucose for 150 min that established a stable hyperglycemia of 8 mmol/liter. There was a concomitant intravenous infusion of one of the following: (1) saline, (2) GLP-1 (for 60 min at 0.3 pmol . kg-1 . min-1 that established physiological postprandial plasma levels, and for another 60 min at 0.9 pmol . kg-1 . min-1 to induce supraphysiological plasma levels), (3-5) ex(9-39)NH2 at 30, 60, or 300 pmol . kg-1 . min-1 + GLP-1, (6-8) ex(9-39)NH2 at 30, 60, or 300 pmol . kg-1 . min-1 + saline, (9 and 10) GIP (glucose-dependent insulinotropic peptide; for 60 min at 0.8 pmol . kg-1 . min-1, with saline or ex(9-39)NH2 at 300 pmol . kg-1 . min-1). Each volunteer received each of these concomitant infusions on separate days. ex(9-39)NH2 dose-dependently reduced the insulinotropic action of GLP-1 with the inhibitory effect declining with increasing doses of GLP-1. ex(9-39)NH2 at 300 pmol . kg-1 . min-1 blocked the insulinotropic effect of physiological doses of GLP-1 and completely antagonized the glucagonostatic effect at both doses of GLP-1. Given alone, this load of ex(9-39)NH2 increased plasma glucagon levels during euglycemia and hyperglycemia. It had no effect on plasma levels of insulin during euglycemia but decreased plasma insulin during hyperglycemia. ex(9-39)NH2 did not alter GIP-stimulated insulin secretion. These data indicate that in humans, ex(9-39)NH2 is a potent GLP-1 antagonist without any agonistic properties. The pancreatic A cell is under a tonic inhibitory control of GLP-1. At hyperglycemia, the B cell is under a tonic stimulatory control of GLP-1.


Assuntos
Glucagon/antagonistas & inibidores , Fragmentos de Peptídeos/antagonistas & inibidores , Fragmentos de Peptídeos/farmacologia , Precursores de Proteínas/antagonistas & inibidores , Receptores de Glucagon/antagonistas & inibidores , Adulto , Peptídeo C/sangue , Glucagon/sangue , Peptídeo 1 Semelhante ao Glucagon , Receptor do Peptídeo Semelhante ao Glucagon 1 , Glucose/metabolismo , Humanos , Insulina/sangue , Masculino , Fragmentos de Peptídeos/sangue , Precursores de Proteínas/sangue , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...